These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37416919)
1. Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience. Matassini MV; Marini M; Angelozzi A; Angelini L; Shkoza M; Compagnucci P; Falanga U; Battistoni I; Pongetti G; Francioni M; Piva T; Mucaj A; Nicolini E; Maolo A; Di Eusanio M; Munch C; Dello Russo A; Perna G Front Cardiovasc Med; 2023; 10():1171956. PubMed ID: 37416919 [TBL] [Abstract][Full Text] [Related]
2. The "TIDE"-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach. Tschöpe C; Spillmann F; Potapov E; Faragli A; Rapis K; Nelki V; Post H; Schmidt G; Alogna A Front Cardiovasc Med; 2021; 8():563484. PubMed ID: 33681302 [No Abstract] [Full Text] [Related]
3. Prolonged Impella 5.0/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center. Pieri M; Ortalda A; Altizio S; Bertoglio L; Nardelli P; Fominskiy E; Lapenna E; Ajello S; Scandroglio AM Front Cardiovasc Med; 2024; 11():1379199. PubMed ID: 39015682 [TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock. Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238 [TBL] [Abstract][Full Text] [Related]
5. Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry. Iannaccone M; Franchin L; Burzotta F; Botti G; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Masiero G; Di Biasi M; Pagnotta P; Casu G; Scandroglio AM; Tarantini G; Chieffo A J Pers Med; 2023 May; 13(5):. PubMed ID: 37240996 [TBL] [Abstract][Full Text] [Related]
7. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047 [TBL] [Abstract][Full Text] [Related]
8. Cardiac power output index to define hemodynamic response to Impella support in cardiogenic shock. Sern Lim H Int J Artif Organs; 2022 Jul; 45(7):598-603. PubMed ID: 35578554 [TBL] [Abstract][Full Text] [Related]
9. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device. Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947 [TBL] [Abstract][Full Text] [Related]
10. Fulminant lymphocytic myocarditis: Prediction of successful weaning from Impella support for cardiogenic shock. Saegusa H; Komatsu J; Sugane H; Hosoda H; Imai RI; Nakaoka Y; Nishida K; Seki SI; Kubokawa SI; Kawai K; Hamashige N; Doi Y J Cardiol Cases; 2022 Mar; 25(3):159-162. PubMed ID: 35261701 [TBL] [Abstract][Full Text] [Related]
11. Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device. Radakovic D; Zittermann A; Knezevic A; Razumov A; Opacic D; Wienrautner N; Flottmann C; Rojas SV; Fox H; Schramm R; Morshuis M; Rudolph V; Gummert J; Deutsch MA Interact Cardiovasc Thorac Surg; 2022 Jan; 34(1):137-144. PubMed ID: 34999807 [TBL] [Abstract][Full Text] [Related]
12. A Novel Predictive Score Model for Successful Weaning From Mechanical Circulatory Support in Patients With Cardiogenic Shock. Suzuki S; Teraoka N; Ito K; Okuma Y; Kimura K; Minamisawa M; Ebisawa S; Motoki H; Imamura H; Seto T; Kuwahara K J Card Fail; 2024 Aug; ():. PubMed ID: 39147310 [TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock. Bhatia K; Jain V; Hendrickson MJ; Aggarwal D; Aguilar-Gallardo JS; Lopez PD; Narasimhan B; Wu L; Arora S; Joshi A; Tomey MI; Mahmood K; Qamar A; Birati EY; Fox A Am J Cardiol; 2022 Oct; 181():94-101. PubMed ID: 35999070 [TBL] [Abstract][Full Text] [Related]
14. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366 [TBL] [Abstract][Full Text] [Related]
15. Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients. Vandenbriele C; Balthazar T; Wilson J; Adriaenssens T; Davies S; Droogne W; Dubois C; Caetano AF; Goetschalckx K; Jacobs S; Janssens S; Ledot S; Meyns B; Soliman-Aboumarie H; Verbrugghe P; Price S Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):415-421. PubMed ID: 33620436 [TBL] [Abstract][Full Text] [Related]
16. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience. Almalla M; Kersten A; Altiok E; Marx N; Schröder JW Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic assessment and risk classification for successful weaning of Impella in patients with cardiogenic shock. Ikeda Y; Ishii S; Maemura K; Oki T; Yazaki M; Fujita T; Iida Y; Kinoshita D; Sato N; Ako J Artif Organs; 2022 Jul; 46(7):1358-1368. PubMed ID: 35132664 [TBL] [Abstract][Full Text] [Related]
20. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]